India's bio-economy has grown 8 times in the last 8 years: PM Modi
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
AstraZeneca also played a critical role in the global response to COVID-19.
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
Investment with representation on the Board of Directors and technical know-how
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
This new fund is amongst the largest for the sector in India
Multiples is the first private equity (PE) investor in the company
Subscribe To Our Newsletter & Stay Updated